Skip to content

Digital Sleep Program for College Students with Insomnia

Digital-Based Multimodal Sleep Management Program for College Students with Insomnia: Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06853106
Acronym
DSP-CS
Enrollment
90
Registered
2025-02-28
Start date
2024-04-24
Completion date
2027-07-31
Last updated
2025-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Keywords

Anxiety, Chronotypes, Daytime Sleepiness, Depression, Digital-based Sleep Management, Insomnia, Resilience, Sleep Reactivity, Mindfulness-based Breathing

Brief summary

This randomized controlled trial (RCT) study aims to evaluate the effectiveness of a digital-based multimodal sleep management program compared to a waitlist control group in improving sleep-related outcomes, including insomnia severity, daytime sleepiness, objective sleep parameters, and sleep reactivity to stress, as well as psychological health indices, such as depression, anxiety, and resilience. Additionally, this study seeks to examine the mediating role of different chronotypes in the effectiveness of the sleep intervention on the outcomes of interest.

Detailed description

This is a parallel-group, randomized controlled trial (RCT). 90 participants who experiencing insomnia for at least 3 months with college students will be enrolled. Eligible participants who complete the baseline measurements will be randomly allocated to a digital-based multimodal sleep management program group (N = 45) and a waitlist control group (N = 45). The primary outcome is insomnia severity, assessed using the Insomnia Severity Index (ISI). The secondary outcomes include daytime sleepiness, objective sleep parameters, sleep reactivity, resilience, anxiety, and depression, which will be examined using the Epworth Sleepiness Scale (ESS), a wearable sleep tracker, the Ford Insomnia Response to Stress Test (FIRST), the Brief Resilience Scale (BRS), the State-Trait Anxiety Inventory (STAI), and the Beck Depression Index II (BDI-II), respectively. Additionally, chronotype will be assessed using the Morningness-Eveningness Questionnaire (MEQ) as a moderating role to be tested in this study. All outcomes will be measured at three time points: T0 (baseline assessment), T1 (immediately after the 4-week intervention period), and T2 (4 weeks after the intervention period).

Interventions

The participants in the waitlist control group will be informed that they are on a waiting list during the intervention period, serving as a no-treatment control. They will receive the sleep intervention (i.e., the digital-based sleep management program) four weeks after the intervention period is completed.

BEHAVIORALdigital-based multimodal sleep management program

The digital-based multimodal sleep management program consists of (1) sleep hygiene education, (2) sleep restriction, and (3) mindfulness breathing exercises. The program is internet-integrated and delivered via Google Meet, with 45-minute weekly sessions over four weeks. To increase participants' adherence to the sleep management program , the course instructor will request the participants to record their daily sleep diaries (time to bed, time to sleep, wake time during sleep and wake time) and sleep journals(practices of sleep hygiene, sleep restriction and mindfulness breathing exercise) in the mobile app for at least five consecutive days each week.

Sponsors

National Science and Technology Council, Taiwan
CollaboratorOTHER_GOV
Taipei Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

We will implement a double-masking protocol, ensuring that assessors and data collectors are all blinded to group assignments. Additionally, group assignments will also be masked from the data analyzer to minimize potential bias.

Eligibility

Sex/Gender
ALL
Age
18 Years to 26 Years
Healthy volunteers
Yes

Inclusion criteria

1. Registered as a full-time student 2. Aged 18 to 26 years old 3. Experiencing insomnia for at least three months 4. Currently own and use a personal mobile device 5. Ability to read and speak Chinese 6. Not taking hypnotics, sedatives, or antidepressants 7. Not pregnant or lactating

Exclusion criteria

1. Using a smartphone model that cannot support the app 2. Currently using other sleep program apps 3. Meeting a STOP-BANG score of ≥3

Design outcomes

Primary

MeasureTime frameDescription
Insomnia Severity:The Insomnia Severity Index (ISI)T0 = baseline; T1 = immediately after intervention; T2 = 4 weeks after intervention.The Insomnia Severity Index (ISI) consists of seven items that assess the current perception of the severity of three insomnia symptoms. Each item is rated on a 5-point Likert scale, with the total score ranging from 0 to 28. Higher scores indicate greater severity of insomnia.

Secondary

MeasureTime frameDescription
Daytime Sleepiness:The Epworth Sleepiness Scale (ESS)T0 = baseline; T1 = immediately after sleep intervention; T2 = 4 weeks after intervention.The Epworth Sleepiness Scale (ESS) is a self-reported measure of daytime sleepiness, assessing the propensity to doze or fall asleep during eight common daily activities. Each situation is rated on a 4-point scale, ranging from 0 (would never doze) to 3 (high chance of dozing). The total score, obtained by summing the scores of the eight items, ranges from 0 to 24, with higher scores indicating greater levels of daytime sleepiness.
Sleep ParametersT0 = baseline; T1 = immediately after sleep intervention; T2 = 4 weeks after interventionThe sleep parameters will be recorded using a wearable sleep tracker (oCare Wrist-Worn Pro 100, Taiwan Biophotonic Corporation, Taiwan) daily for five consecutive days both before and immediately after the intervention. The wearable device will be paired with a mobile app for data collection and analysis. The sleep parameters derived from the device include sleep onset latency (SOL), wake after sleep onset (WASO), time in bed (TIB), total sleep time (TST), and sleep efficiency (SE).
Sleep Reactivity: The Chinese version of the Ford Insomnia Response to Stress Test (FIRST)T0 = baseline; T1 = immediately after sleep intervention; T2 = 4 weeks after interventionThe Ford Insomnia Response to Stress Test (FIRST) measures the extent to which sleep is affected by stress in individuals experiencing stressful conditions. It is a self-administered questionnaire consisting of nine questions, each rated on a 4-point scale, ranging from 1 (unlikely to happen) to 4 (very likely to happen). The total score ranges from 9 to 36, with higher scores indicating a greater degree of sleep disruption due to stress.
Depression: The Beck Depression Index II (BDI II)T0 = baseline; T1 = immediately after sleep intervention; T2 = 4 weeks after interventionThe Beck Depression Inventory-II (BDI-II) is a 21-item questionnaire designed to assess depressive symptoms. Response options range from 0 (did not feel it) to 3 (most or almost all the time). The total score ranges from 0 to 63, with higher scores indicating greater severity of depressive symptoms.
Anxiety: The State Trait Anxiety Inventory (STAI)T0 = baseline; T1 = immediately after sleep intervention; T2 = 4 weeks after interventionThe State-Trait Anxiety Inventory (STAI) is a self-report scale used to assess anxiety symptoms. It consists of 40 items, divided into two distinct dimensions: trait anxiety (20 items) and state anxiety (20 items). Each item is rated on a 4-point Likert scale, ranging from almost never to almost always, with higher scores indicating greater levels of anxiety.
Resilience: The Chinese version of the Brief Resilience Scale (BRS)T0 = baseline; T1 = immediately after sleep intervention; T2 = 4 weeks after interventionThe Brief Resilience Scale (BRS) consists of six questions, each rated on a 5-point Likert scale, ranging from 1 (strongly disagree) to 5 (strongly agree). Questions 1, 3, and 5 are forward-scored, while questions 2, 4, and 6 are reverse-scored. The total score ranges from 5 to 25, with higher scores indicating greater resilience, reflecting an individual's ability to adapt and recover from adverse events.

Other

MeasureTime frameDescription
Chronotype: The Chinese version of the Morningness-Eveningness Questionnaire (MEQ)T0 = baseline; T1 = immediately after sleep intervention; T2 = 4 weeks after interventionThe Morningness-Eveningness Questionnaire (MEQ) is a self-administered questionnaire consisting of 19 questions that assess an individual's preferred bedtime, wake-up time, and activity time. Responses are scored on a Likert-type scale, with total scores ranging from 16 to 86, reflecting differences in circadian rhythms. Higher scores indicate a stronger tendency to be a morning-type individual.

Countries

Taiwan

Contacts

Primary ContactPei-Shan Tsai, PhD
ptsai@tmu.edu.tw+886227361661

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026